Exjade 125 mg Dispersible Tablet
Country: Philippines
Language: English
Source: FDA (Food And Drug Administration)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Deferasirox
Available from:
Novartis Healthcare Philippines, Inc.
INN (International Name):
Deferasirox
Dosage:
125 mg
Pharmaceutical form:
Dispersible Tablet
Units in package:
PVC/PE/PVDC Blister Pack x 7's (Box of 28's), PA/AL/PVC (Alu) Blister pack x 7's (box of 28's)
Manufactured by:
Sandoz S.R.L., Romania
Authorization date:
2022-09-14
